GT Biopharma, Inc. (GTBP) Financials

$2.18

north_east
$0.05 (2.35%)
Day's range
$2.09
Day's range
$2.2
$0$0-$50M-$50M-$100M-$100M-$150M-$150M-$200M-$200M-$250M-$250M-$300M-$300MEarning201720172018201820192019202020202021202120222022202320236%6%5%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

GTBP Income statement / Annual

Last year (2023), GT Biopharma, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, GT Biopharma, Inc.'s net income was -$7.60 M. See GT Biopharma, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $27,000.00 $61,000.00
Cost of Revenue $0.00 $0.00 $0.00 $0.00 $4,000.00 $7,000.00 $2,000.00 $1,000.00 $2,000.00 $57,000.00
Gross Profit $0.00 $0.00 $0.00 $0.00 -$4,000.00 -$7,000.00 -$2,000.00 -$1,000.00 $25,000.00 $4,000.00
Gross Profit Ratio 0 0 0 0 0 0 0 0 0.93 0.07
Research and Development Expenses $6.47 M $8.81 M $9.59 M $485,000.00 $1.67 M $9.07 M $1.07 M $975,000.00 $1.00 M $0.00
General & Administrative Expenses $0.00 $0.00 $47.92 M $6.28 M $9.79 M $12.49 M $0.00 $0.00 $0.00 $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $7.11 M $12.45 M $47.92 M $6.28 M $9.79 M $12.49 M $134.50 M $8.40 M $7.95 M $2.40 M
Other Expenses $0.00 $0.00 -$242,760.00 -$12.60 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $13.58 M $21.26 M $57.52 M $6.76 M $11.46 M $21.55 M $135.57 M $9.37 M $8.95 M $2.40 M
Cost And Expenses $13.58 M $21.26 M $57.52 M $6.76 M $11.46 M $21.55 M $135.57 M $9.37 M $8.95 M $2.46 M
Interest Income $567,000.00 $292,000.00 $38,000.00 $3,320.00 $2,128.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $8,000.00 $718,000.00 $3.32 M $2.13 M $9.12 M $8.60 M $6.56 M $17.04 M $5.15 M
Depreciation & Amortization $13.58 M $21.26 M $57.52 M $4,000.00 $4,000.00 $7,000.00 $2,000.00 $1,000.00 $2,000.00 $22,000.00
EBITDA $5.98 M $0.00 $0.00 -$24.98 M -$11.45 M -$250.06 M -$135.57 M -$9.37 M -$8.93 M -$2.37 M
EBITDA Ratio 0 0 0 0 0 0 0 0 -330.56 -38.92
Operating Income Ratio 0 0 0 0 0 0 0 0 -330.63 -39.28
Total Other Income/Expenses Net $5.98 M $373,000.00 -$498,000.00 -$21.53 M -$22.59 M -$9.12 M -$7.68 M $19.14 M -$12.53 M -$21.11 M
Income Before Tax -$7.60 M -$20.88 M -$58.01 M -$28.30 M -$38.65 M -$259.19 M -$143.25 M $21.03 M -$32.73 M -$23.49 M
Income Before Tax Ratio 0 0 0 0 0 0 0 0 -1212.07 -385.07
Income Tax Expense $0.00 -$381,000.00 $680,000.00 $3.32 M $2.13 M -$228.52 M $7.68 M -$30.41 M $17.04 M $5.15 M
Net Income -$7.60 M -$20.50 M -$58.69 M -$31.62 M -$40.78 M -$259.19 M -$143.25 M $21.03 M -$32.73 M -$23.49 M
Net Income Ratio 0 0 0 0 0 0 0 0 -1212.07 -385.07
EPS -5.64 -19.3 -62.54 -216.29 -361.49 -87.7 -145.22 4390.11 -69629.79 -50622.84
EPS Diluted -5.64 -19.3 -62.54 -216.29 -361.49 -87.7 -145.22 4390.11 -69629.79 -50622.84
Weighted Average Shares Out $1.35 M $1.06 M $938,520.00 $146,172.00 $112,798.00 $2.96 M $986,419.00 $4,791.00 $470.00 $464.00
Weighted Average Shares Out Diluted $1.35 M $1.06 M $938,520.00 $146,172.00 $112,798.00 $2.96 M $986,419.00 $4,791.00 $470.00 $464.00
Link